Reimbursement Recommendations Based on Phase II Clinical Evidence for Oncology Drugs in Canada
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1496
https://www.valueinhealthjournal.com/article/S1098-3015(16)01564-3/fulltext
Title :
Reimbursement Recommendations Based on Phase II Clinical Evidence for Oncology Drugs in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01564-3&doi=10.1016/j.jval.2016.03.1496
First page :
A163
Section Title :
Cancer - Health Care Use & Policy Studies
Open access? :
No
Section Order :
390